Journal of Pain Research
Myofascial Trigger Point–Augmented Acupuncture vs Conventional Acupuncture for Early- to Mid-Stage Knee Osteoarthritis: A Randomized Clinical Trial [Response to Letter]
By Longyao Zhang, Jiankang Xu, Lingling Jiang and 5 others.
Abstract
We thank Xu and Zhou for their thoughtful comments on our randomized clinical trial.1,2 We would like to clarify three issues concerning myofascial trigger point (MTrP) characterization, gait terminology, and sample-size estimation.First, our trial was designed to evaluate the incremental effect of adding individualized MTrP-targeted needling to an otherwise identical conventional acupuncture regimen in patients with early-to mid-stage knee osteoarthritis.The presence of an MTrP was therefore not an eligibility criterion.For participants in the MTrP-augmented group, clinicians received standardized training in the prespecified identification criteria and 4-grade tenderness scale.Before the first treatment, two trained physicians separately assessed candidate peri-knee sites, primarily in the vastus medialis and gastrocnemius, and measured pressure pain threshold.Three grade 3 or 4 sites with the greatest tenderness were selected, photographed, and documented, and the same sites were treated throughout all 10 sessions.All participants assigned to the MTrP-augmented group had at least three sites meeting these criteria; therefore, no participant was treated at fewer than three qualifying sites.Systematic MTrP mapping was performed for treatment selection in the augmented group rather than as a baseline phenotyping procedure in both groups.Consequently, MTrP number and muscle distribution were not collected as comparative baseline variables in the conventional acupuncture group.We agree that this prevents a formal comparison of baseline MTrP burden between groups and should be considered when interpreting MTrP-specific findings.Second, we appreciate the authors' observation regarding the gait-phase terminology.After rechecking the original device output and dataset, we confirmed that the variable reported as "single-leg support time" corresponds to the stance phase of the analyzed limb rather than to the biomechanically defined single-limb support period.The gait-analysis device used in our study reports the relevant variables in Chinese, and during preparation of the English-language manuscript, the Chinese term corresponding to the stance/support phase was translated imprecisely as "single-leg support time."The device-derived gait cycle was partitioned into stance phase and swing phase, which together constitute 100% of the gait cycle.This explains both their complementary values and their equal-and-opposite longitudinal changes.The issue therefore concerns terminology rather than the original device output, numerical values, or statistical calculations; the effect estimates, confidence intervals, and P values remain unchanged.







